Teva Pharmaceuticals
TEVA
TEVA
427 hedge funds and large institutions have $5.13B invested in Teva Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 123 increasing their positions, 142 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
427
Holders Change
-12
Holders Change %
-2.73%
% of All Funds
7.5%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
34
Increased
123
Reduced
142
Closed
40
Calls
$296M
Puts
$315M
Net Calls
-$18.9M
Net Calls Change
+$23.5M
Top Buyers
| 1 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
$191M |
| 2 |
BMO
Beck Mack & Oliver
New York
|
$71.7M |
| 3 |
PF
Phoenix Financial
Givatayim,
Israel
|
$138M |
| 4 |
Jane Street
New York
|
$43.2M |
| 5 |
D.E. Shaw & Co
New York
|
$26.3M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
$60.2M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
$1.16B |
| 3 |
Norges Bank
Oslo,
Norway
|
$2.94M |
| 4 |
Citigroup
New York
|
$20.3M |
| 5 |
JPMorgan Chase & Co
New York
|
$5.75M |
